コーパス検索結果 (１語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 reatment with a GlyT1 inhibitor or any other investigational drug.
2 ntral fat accumulation were recorded for the investigational drug.
3 act as suitable carriers for the delivery of investigational drugs.
4 o as to improve the efficacy of approved and investigational drugs.
5 creasing prevalence of allosteric ligands as investigational drugs.
6 cell invasive potential form a new class of investigational drugs.
7 s new "breakthrough therapy" designation for investigational drugs adds to the agency's portfolio of
8 d and Drug Administration (FDA)-approved and investigational drugs against hundreds of targets, defin
9 d compare the various therapeutic platforms, investigational drugs, and clinical trials targeting geo
10 l of these proteins have been the targets of investigational drugs, and epidermal growth factor recep
11 leading drug candidates, several designated investigational drugs, and some medical devices, as well
12 ng to abandonment of potentially efficacious investigational drugs, and unexpected deadly adverse eve
14 his challenge by testing 128 FDA-approved or investigational drugs as either single agents or in 768
15 research on adherence to placebo-controlled investigational drug by way of drug detection in active-
16 ne-3-carboxamide (VX-770, 48, ivacaftor), an investigational drug candidate approved by the FDA for t
17 asma concentration-time results of NVP-1, an investigational drug candidate, observed in the plasma s
18 F-FDG PET for guiding the selection of novel investigational drugs, choosing dose in early-phase clin
20 atory scrutiny that affects manufacturers of investigational drugs for early-phase clinical trials en
22 increases greater than those seen with other investigational drugs in this class and LDL-C lowering e
24 ating agents (HMAs), lenalidomide (LEN), and investigational drugs, may be used after ESA failure in
28 are randomized to standard therapy plus the investigational drug or standard therapy plus placebo ar
31 d in a 3:1:1 ratio to receive fixed doses of investigational drug, placebo, or haloperidol for 6 week
33 ngs show that transient exposure to this new investigational drug should be useful for controlling p5
34 Task Force of the National Cancer Institute Investigational Drug Steering Committee convened an inte
35 ly reproducible and allows for evaluation of investigational drugs targeting IL-6-dependent MM cells
36 biology of WM and allows the study of novel investigational drugs targeting WM cells in the huBM mil
37 an hepatitis C immune globulin Civacir is an investigational drug that is currently being developed i
38 atitis C immunoglobulin (HCIG) Civacir is an investigational drug that is currently being developed i
39 r (VEGF) therapy and ionizing radiation, and investigational drugs that address different targets alo
40 ents, has led to the clinical development of investigational drugs that restore function to defective
42 nd some of the limitations of this important investigational drug, these findings clearly demonstrate
45 ity defect can be partially corrected by the investigational drug VX-809 (3-[6-[[[1-(2,2-difluoro-1,3
46 at several of these compounds, including the investigational drug VX-809, caused a much greater incre
50 the basis of these data, multiarm studies of investigational drugs will require 25 evaluable subjects
WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。